This article was originally published under standard licence, but has now been made available under a [CC BY 4.0] license. The PDF and HTML versions of the paper have been modified accordingly.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608235 | PMC |
| http://dx.doi.org/10.1038/s41380-019-0349-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Body dysmorphic disorder.
Nat Rev Dis Primers
December 2024
Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Healthcare Services, Region Stockholm, Stockholm, Sweden.
Body dysmorphic disorder (BDD) is an obsessive-compulsive disorder-related psychiatric condition characterized by an intense preoccupation with perceived physical flaws that are not observable by others. BDD affects ~2% of the adult population but is underdiagnosed, partly owing to limited clinician awareness, and undertreated, partly due to limited access to treatment. Research on the aetiology of BDD is scarce but likely involves an interplay between genetic and environmental factors.
View Article and Find Full Text PDFImpact of antidepressant use on survival outcomes in glioma patients: A systematic review and meta-analysis.
Neurooncol Adv
October 2024
Department of Neurosurgery, Center for Malignant Brain Tumors, National Glioma MDT Alliance, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Depression is common among glioma patients, and antidepressants are frequently prescribed to manage symptoms. Understanding the impact of antidepressants on glioma patient survival is crucial for informing treatment strategies.
Methods: A systematic search was conducted in PubMed and EMBASE databases for studies published from January 1994 to March 2024.
Cavitating Osmotic Demyelination Syndrome Following Correction of Chronic Hyponatremia in Sheehan's Syndrome: A Novel Case Report.
Neurohospitalist
September 2024
Department of Neurology, University Hospital "12 de Octubre", Madrid, Spain.
Article Synopsis
- Rapid correction of chronic hyponatremia can lead to osmotic demyelination syndrome (ODS), especially in patients with underlying conditions like Sheehan’s syndrome, a rare pituitary disorder following severe postpartum hemorrhage.
- A case report details a 40-year-old woman who experienced neurological decline due to the correction of her long-standing hyponatremia, which had been mismanaged for years, leading to extrapontine and then central pontine myelinolysis.
- The case emphasizes that even gradual correction of low sodium levels poses risks and highlights the need for careful management in patients with chronic hyponatremia and related conditions.
Clinical effects of CYP2D6 phenoconversion in patients with psychosis.
J Psychopharmacol
December 2024
Outpatient Clinic Pharmacogenetics, Parnassia Groep, Amsterdam, The Netherlands.
Background: Pharmacogenetics is considered a promising avenue for improving treatment outcomes, yet evidence arguing for the use of pharmacogenetics in the treatment of psychotic disorders is mixed and clinical usefulness is under debate. Many patients with psychosis use multiple medications, which can alter the metabolic capacity of enzymes, a process called phenoconversion. In clinical studies, treatment outcomes of drugs for psychosis management may have been influenced by phenoconversion.
View Article and Find Full Text PDFInvestigating Neuroplasticity Changes Reflected by BDNF Levels in Astrocyte-Derived Extracellular Vesicles in Patients with Depression.
Int J Nanomedicine
September 2024
Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
Article Synopsis
- The study explores the neuroplasticity hypothesis in depression by measuring BDNF levels in astrocyte-derived extracellular vesicles from patients with major depressive disorder (MDD) and healthy controls.
- Results show that MDD patients have higher levels of CD81 and lower levels of BDNF in their ADEVs compared to controls, with improvements noted after SSRIs treatment.
- The findings suggest that ADEVs might be more reliable biomarkers for depression than conventional plasma markers, highlighting their potential in understanding and diagnosing the condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!